How are anticholinergics used in Parkinson’s disease?

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts

How are anticholinergics used in Parkinson’s disease?

Anticholinergics are a class of medications that are sometimes used in the treatment of Parkinson’s disease (PD). Their use, however, has become more limited over time due to the availability of other more effective and better-tolerated treatments. Here’s how anticholinergics are used and what their role is in managing Parkinson’s disease:

Role of Anticholinergics in Parkinson’s Disease

Primary Use:
- Tremor Control: Anticholinergics are primarily used to manage tremor, particularly in younger patients with Parkinson’s disease who experience prominent tremor as their main symptom. Tremor is less responsive to Levodopa and dopamine agonists, so anticholinergics can sometimes be added to address this specific issue.
Mechanism of Action:
- Parkinson’s disease causes an imbalance between the neurotransmitters dopamine and acetylcholine in the brain. As dopamine levels decrease due to the degeneration of neurons in the substantia nigra, acetylcholine levels remain unopposed, contributing to some of the motor symptoms of Parkinson’s, particularly tremors. Anticholinergics work by blocking acetylcholine receptors, helping to restore a better balance between dopamine and acetylcholine, thereby reducing tremor and rigidity in some patients.
Commonly Used Anticholinergic Medications in Parkinson’s Disease:
- Benztropine (Cogentin)
- Trihexyphenidyl (Artane)
Patient Selection:
- Younger Patients: Anticholinergics are more likely to be used in younger individuals with Parkinson’s disease because they tend to tolerate the side effects better than older patients. The risk of cognitive side effects (such as confusion, memory impairment, and hallucinations) increases with age, so these drugs are generally avoided in older patients or those with cognitive decline.
- Mild to Moderate Symptoms: Anticholinergics may be used when tremor is a dominant symptom, and other medications like Levodopa or dopamine agonists have not adequately controlled it.

Limitations and Side Effects:

Despite their potential effectiveness in treating tremor, anticholinergics have significant limitations due to their side effect profile, which has led to their more selective use in Parkinson’s disease treatment.

Cognitive Effects:
- Anticholinergics can impair memory, cause confusion, and exacerbate or trigger dementia-like symptoms. This is a major reason why these drugs are rarely used in older Parkinson’s patients or those with existing cognitive problems.
Peripheral Side Effects:
- Dry Mouth
- Blurred Vision
- Urinary Retention
- Constipation
- Tachycardia (rapid heartbeat)
Risk of Dependency:
- Because of the central and peripheral effects of anticholinergics, long-term use can lead to dependency and difficulty in discontinuing the medication due to withdrawal symptoms or a rebound of tremors.

Current Clinical Use:

Due to these side effects, anticholinergics are now less commonly prescribed than they were in the past. In modern treatment plans for Parkinson’s disease, anticholinergics are usually reserved for:

Young patients with predominantly tremor-dominant Parkinson’s.
Patients who do not tolerate or respond well to Levodopa or dopamine agonists for tremor control.
Cases where other treatment options are limited or contraindicated.

Anticholinergics are not typically a first-line treatment and are often used as a supplementary or adjunctive therapy for specific symptoms when other medications have been insufficient.

Alternatives:

Given the risks associated with anticholinergics, many patients are transitioned to other treatments like Levodopa, dopamine agonists, or newer medications like MAO-B inhibitors or COMT inhibitors, which tend to have fewer cognitive side effects.

In conclusion, while anticholinergics can be helpful for controlling tremors in Parkinson’s disease, their use is now limited due to the potential for significant cognitive and peripheral side effects, particularly in older adults.

Jodi Knapp